Talphera (NASDAQ:TLPH – Get Free Report) is set to issue its quarterly earnings data after the market closes on Wednesday, November 13th. Analysts expect the company to announce earnings of ($0.20) per share for the quarter. Parties that are interested in participating in the company’s conference call can do so using this link.
Talphera (NASDAQ:TLPH – Get Free Report) last issued its earnings results on Wednesday, August 14th. The company reported ($0.15) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.22) by $0.07. On average, analysts expect Talphera to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.
Talphera Price Performance
Shares of TLPH opened at $0.89 on Tuesday. Talphera has a 12-month low of $0.43 and a 12-month high of $1.61. The business’s 50 day moving average is $0.91 and its 200 day moving average is $0.94.
Wall Street Analyst Weigh In
Read Our Latest Analysis on Talphera
Talphera Company Profile
Talphera, Inc, a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. Its lead product candidate is Niyad, a lyophilized formulation of nafamostat, which is under an investigational device exemption as an anticoagulant for the extracorporeal circuit.
Featured Stories
- Five stocks we like better than Talphera
- What Are Growth Stocks and Investing in Them
- 2 Chip Stocks Benefitting from OpenAI’s Chip Strategy Expansion
- How to Start Investing in Real Estate
- Monday.com’s Manic Price Pullback Is a Signal to Buy
- How to Invest in the Best Canadian Stocks
- 3 “Made in America” Stocks to Benefit From the Trump Presidency
Receive News & Ratings for Talphera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Talphera and related companies with MarketBeat.com's FREE daily email newsletter.
